« Back to Record
Huober, J., Holmes, E., Baselga, J., de Azambuja, E., Untch, M., Fumagalli, D., Sarp, S., Lang, I., Smith, I., Boyle, F., Xu, B., Lecocq, C., Wildiers, H., Jouannaud, C., Hackman, J., Dasappa, L., Ciruelos, E., Toral-Peña, J. C., Adamchuk, H., Hickish, T., de la Peña, L., Jackisch, C., Gelber, R., Piccart-Gebhart, M., & Di Cosimo, S. (2019). Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer. European journal of cancer, 118, 169-177. doi:10.1016/j.ejca.2019.04.038
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/296554



